1
|
Al-Bashish S, Ababneh E, Mousa MS, Okoor S, Hyasat M, Nusir M, Qbelat A, Dababneh S. Offline coincidence/anti-coincidence techniques by BALQARAD active shielded clover. Radiat Detect Technol Methods 2021. [DOI: 10.1007/s41605-021-00265-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
2
|
Ababneh E, Dermawan J, Thomas M, Wang X, Blank A, Bakhshwin A, Terzioglu M, Miller B, Shah A, Griffith C, Chute D. Optimizing the Handling of Invasive Fungal Sinusitis Surgical Specimens. Am J Clin Pathol 2020. [DOI: 10.1093/ajcp/aqaa161.273] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction/Objective
Invasive fungal sinusitis (IFS) is an aggressive disease characterized by invasion of fungal hyphae into tissue/neurovascular bundles. This project assessed the handling of IFS specimens and implemented protocols to improve turnaround time (TAT).
Methods
A retrospective review of cases accessioned with a clinical concern for IFS from 2014-2019 was performed. TAT for each step in the specimen processing was recorded. A flowchart was created using stakeholder interviews and a revised protocol was developed after assessing critical needs. Assessment of interventions was performed following implementation of the new protocol. The protocol will be evaluated by prospective direct case-by-case feedback and after a 6-month interval (projected August/2020). At 6-months, goals are a 24 hours median time between frozen section and sign-out and elimination of outliers (greater than 2 working days).
Results
We identified 53 specimens from 32 patients in the pre-intervention period (36 cases positive for IFS). Median time from frozen section to final sign-out was 28 (5-312) hours. Four areas for improvements were identified:
(1) triaging specimens to different protocols according to arrival time, (2) optimized triaging for available histology processors, (3) standardized GMS ordering, and (4) standardized case delivery/communication with sign-out staff. Interventions include: protocol for processing specimens based on time of day, new histology protocols to expedite GMS performance, an email group for rapid communication with staff pathologists and histology, and a worksheet/checklist to track each case. After implementation of the protocol, 8 cases from 7 patients were received. Median time from frozen section to final sign-out was reduced to 20 (2 – 50) hours.
Conclusion
The protocol for handling IFS specimens became live on 2/1/2020. It has reduced TAT of suspected IFS cases, from a median of 28 hours to 20 hours. The longest interval to sign-out went from312 hours to 50 hours.
Collapse
Affiliation(s)
- E Ababneh
- Pathology and laboratory medicine, Cleveland Clinic Foundation, Cleveland, Ohio, UNITED STATES
| | - J Dermawan
- Pathology and laboratory medicine, Cleveland Clinic Foundation, Cleveland, Ohio, UNITED STATES
| | - M Thomas
- Pathology and laboratory medicine, Cleveland Clinic Foundation, Cleveland, Ohio, UNITED STATES
| | - X Wang
- Pathology and laboratory medicine, Cleveland Clinic Foundation, Cleveland, Ohio, UNITED STATES
| | - A Blank
- Pathology and laboratory medicine, Cleveland Clinic Foundation, Cleveland, Ohio, UNITED STATES
| | - A Bakhshwin
- Pathology and laboratory medicine, Cleveland Clinic Foundation, Cleveland, Ohio, UNITED STATES
| | - M Terzioglu
- Pathology and laboratory medicine, Cleveland Clinic Foundation, Cleveland, Ohio, UNITED STATES
| | - B Miller
- Pathology and laboratory medicine, Cleveland Clinic Foundation, Cleveland, Ohio, UNITED STATES
| | - A Shah
- Pathology and laboratory medicine, Cleveland Clinic Foundation, Cleveland, Ohio, UNITED STATES
| | - C Griffith
- Pathology and laboratory medicine, Cleveland Clinic Foundation, Cleveland, Ohio, UNITED STATES
| | - D Chute
- Pathology and laboratory medicine, Cleveland Clinic Foundation, Cleveland, Ohio, UNITED STATES
| |
Collapse
|